Is it Time to Dump Your Shares of Moderna?

Although you may not exactly understand what Moderna (NASDAQ: MRNA) does, you probably know the company's name, given its involvement in the coronavirus pandemic. The messenger RNA technology, or mRNA, the company uses to produce medicines is exciting, and it helped fast-track a working vaccine to fight back against COVID-19. But its success there doesn't necessarily mean you want to hold on to the stock.Here are five important considerations if you are thinking about Moderna as an investment.The main reason to buy Moderna is its use of mRNA technology to develop novel medicines. Messenger RNA is extremely complex, but it allows for the rapid development of lifesaving new drugs. The big proof point of this was the coronavirus vaccine that Moderna helped create during the pandemic. And that's just one example of what this healthcare company has done and can do.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool